ClinDrops for Cats & Dogs

ClinDrops® Oral Drops (for use in dogs and cats) are indicated for the treatment of bacterial infections including oral, deep skin, and bone infections.

• Is a palatable formulation intended for oral administration.
• Treats oral, deep skin, and bone infections
• Each mL of ClinDrops® Oral Drops liquid contains clindamycin hydrochloride equivalent to 25 mg clindamycin
• For use in cats and dogs

Each mL of ClinDrops® Oral Drops liquid contains clindamycin hydrochloride equivalent to 25 mg clindamycin; and ethyl alcohol, 8.64%.

It is important to follow your Veterinarian's prescription instructions for your pet

ClinDrops® Oral Drops, administer 1-6 mL/10 lbs body weight every 12 hours.

Dogs:

Osteomyelitis:

Oral: 5.0-15.0 mg/lb body weight every 12 hours.

Duration: Treatment with ClinDrop® Oral Drops is recommended for a minimum of 28 days. Treatment should not be continued for longer than 28 days if no response to therapy is seen.

Dosage Schedule: ClinDrops® Oral Drops, administer 2-6 mL/10 lbs body weight every 12 hours.

Cats:

Infected Wounds, Abscesses, and Dental Infections

Oral: 5.0 - 15.0 mg/lb body weight once every 24 hours depending on the severity of the condition.

Duration: Treatment with ClinDrops® Oral Drops may be continued up to a maximum of 14 days if clinical judgment indicates. Treatment of acute infections should not be continued for more than three to four days if no clinical response to therapy is seen.

Dosage Schedule:

to provide 5.0 mg/lb, administer 1 mL/5 lbs body weight once every 24 hours;

to provide 15.0 mg/lb, administer 3 mL/5 lbs body weight once every 24 hours.

Precautions:

Not for human use. Not for use in Pregnant or nursing animals, or pets with allergies, kidney or liver disease.

During prolonged therapy of one month or greater, periodic liver and kidney function tests and blood counts should be performed. The use of ClinDrops® Oral Drops occasionally results in overgrowth of non-susceptible organisms such as clostridia and yeasts. Therefore, the administration of ClinDrops® Oral Drops should be avoided in those species sensitive to the gastrointestinal effects of clindamycin. Should superinfections occur, appropriate measures should be taken as indicated by the clinical situation.

Patients with very severe renal disease and/or very severe hepatic disease accompanied by severe metabolic aberrations should be dosed with caution, and serum clindamycin levels monitored during high-dose therapy.

Clindamycin hydrochloride has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, ClinDrops® Oral Drops should be used with caution in animals receiving such agents.

Safety in gestating bitches and queens or breeding male dogs and cats has not been established.

Possible Side Effects:

Side effects occasionally observed in either clinical trials or during clinical use were vomiting and diarrhea.

Storage

Keep out of reach of children and pets.

Store in a cool dry place, replace cap after each use.